Progression of autosomal-dominant polycystic kidney disease in children.
暂无分享,去创建一个
Ann M. Johnson | P. Gabow | Z. Tran | G. Fick-Brosnahan | A. Johnson | J. Strain | Zung Vu Tran | John D. Strain
[1] Ann M. Johnson,et al. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[2] Ann M. Johnson,et al. Renal asymmetry in children with autosomal dominant polycystic kidney disease. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] Ann M. Johnson,et al. Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease. , 1998, Journal of the American Society of Nephrology : JASN.
[4] B. Lifson,et al. Role and long-term results of laparoscopic decortication in solitary cystic and autosomal dominant polycystic kidney disease. , 1998, The Journal of urology.
[5] Ann M. Johnson,et al. Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. , 1997, Journal of the American Society of Nephrology : JASN.
[6] T. Seeman,et al. Blood pressure and renal function in autosomal dominant polycystic kidney disease , 1997, Pediatric Nephrology.
[7] Dan Wang,et al. The pathogenesis of hypertension in autosomal dominant polycystic kidney disease , 1997, Journal of hypertension.
[8] G. Hawksworth,et al. Selective antagonism of the AT1 receptor inhibits angiotensin II stimulated DNA and protein synthesis in primary cultures of human proximal tubular cells. , 1997, Kidney international.
[9] S. Warkentin,et al. Functional imaging of the frontal lobes in organic dementia. Regional cerebral blood flow findings in normals, in patients with frontotemporal dementia and in patients with Alzheimer's disease, performing a word fluency test. , 1997, Dementia and geriatric cognitive disorders.
[10] P. Gabow,et al. Utility of ultrasonography in the diagnosis of autosomal dominant polycystic kidney disease in children. , 1997, Journal of the American Society of Nephrology : JASN.
[11] P. Jungers,et al. Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. , 1995, Journal of the American Society of Nephrology : JASN.
[12] Ann M. Johnson,et al. Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. , 1994, Journal of the American Society of Nephrology : JASN.
[13] R. Foley,et al. Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members. , 1994, Kidney international.
[14] Ann M. Johnson,et al. The spectrum of autosomal dominant polycystic kidney disease in children. , 1994, Journal of the American Society of Nephrology : JASN.
[15] W. Bennett,et al. Surgical management of painful polycystic kidneys. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] T. Hostetter,et al. Effect of angiotensin II and norepinephrine on early growth response genes in the rat kidney. , 1993, Kidney international.
[17] G. Wolf,et al. Angiotensin II as a hypertrophogenic cytokine for proximal tubular cells. , 1993, Kidney international. Supplement.
[18] S. Geberth,et al. Renal histology in polycystic kidney disease with incipient and advanced renal failure. , 1992, Kidney international.
[19] Ann M. Johnson,et al. Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] J. Mcateer,et al. Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease. , 1992, Kidney international.
[21] Ann M. Johnson,et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. , 1992 .
[22] P. Allan,et al. Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease. , 1992, Kidney international.
[23] A. Chapman,et al. Pathogenesis of hypertension in autosomal dominant polycystic kidney disease. , 1991, Seminars in nephrology.
[24] K. Offord,et al. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease. , 1991, Mayo Clinic proceedings.
[25] R. Harris,et al. Angiotensin actions in the kidney: renewed insight into the old hormone. , 1991, Kidney international.
[26] Ann M. Johnson,et al. Renal structure and hypertension in autosomal dominant polycystic kidney disease. , 1990, Kidney international.
[27] Ann M. Johnson,et al. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. , 1990, The New England journal of medicine.
[28] James R. Thompson. Empirical Model Building , 1989 .
[29] G. Lindop,et al. The anatomy of the renin-secreting cell in adult polycystic kidney disease. , 1988, Kidney international.
[30] L. Brion,et al. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. , 1987, Pediatric clinics of North America.
[31] P. Gabow,et al. Autosomal dominant polycystic kidney disease in childhood: a longitudinal study. , 1987, Kidney international.
[32] W. Bennett,et al. Reduction of cyst volume for symptomatic management of autosomal dominant polycystic kidney disease. , 1987, The Journal of urology.
[33] J. Lott,et al. Evaluation of the Coomassie Brilliant Blue G-250 method for urinary protein. , 1983, Clinical chemistry.
[34] J B Stokes,et al. The national high blood pressure education program. , 1974, Journal of the American Pharmaceutical Association.